Click for best price
Lung Cancer Biomarkers Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for Lung Cancer Biomarkers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lung Cancer Biomarkers. This report contains market size and forecasts of Lung Cancer Biomarkers in global, including the following market information:
Global Lung Cancer Biomarkers Market Revenue, 2018-2023, 2024-2035, ($ millions)
Global Lung Cancer Biomarkers Market Sales, 2018-2023, 2024-2035, (Units)
Global top five Lung Cancer Biomarkers companies in 2022 (%)
The global Lung Cancer Biomarkers market was valued at US$ million in 2022 and is projected to reach US$ million by 2035, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Protein Biomarker Segment to Reach $ Million by 2035, with a % CAGR in next six years.
The global key manufacturers of Lung Cancer Biomarkers include Bio-Rad Laboratories, Roche Diagnostics, Qiagen, Illumina, GE Healthcare, Agilent Technologies, Biomerieux SA, Merck and Abbott Laboratories, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Lung Cancer Biomarkers manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Lung Cancer Biomarkers Market, by Type, 2018-2023, 2024-2035 ($ Millions) & (Units)
Global Lung Cancer Biomarkers Market Segment Percentages, by Type, 2022 (%)
Protein Biomarker
Genetic Biomarker
Global Lung Cancer Biomarkers Market, by Application, 2018-2023, 2024-2035 ($ Millions) & (Units)
Global Lung Cancer Biomarkers Market Segment Percentages, by Application, 2022 (%)
Diagnostics
Research
Others
Global Lung Cancer Biomarkers Market, By Region and Country, 2018-2023, 2024-2035 ($ Millions) & (Units)
Global Lung Cancer Biomarkers Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Lung Cancer Biomarkers revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Lung Cancer Biomarkers revenues share in global market, 2022 (%)
Key companies Lung Cancer Biomarkers sales in global market, 2018-2023 (Estimated), (Units)
Key companies Lung Cancer Biomarkers sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bio-Rad Laboratories
Roche Diagnostics
Qiagen
Illumina
GE Healthcare
Agilent Technologies
Biomerieux SA
Merck
Abbott Laboratories
Becton, Dickinson and Company
Danaher Corporation
Myriad Genetics
Sysmex Corporation
Hologic
Outline of Major Chapters:
Chapter 1: Introduces the definition of Lung Cancer Biomarkers, market overview.
Chapter 2: Global Lung Cancer Biomarkers market size in revenue and volume.
Chapter 3: Detailed analysis of Lung Cancer Biomarkers manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Lung Cancer Biomarkers in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Lung Cancer Biomarkers capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Lung Cancer Biomarkers Market, Global Outlook and Forecast 2023-2035 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
79 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Lung Cancer Biomarkers Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Lung Cancer Biomarkers Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Lung Cancer Biomarkers Overall Market Size
2.1 Global Lung Cancer Biomarkers Market Size: 2022 VS 2035
2.2 Global Lung Cancer Biomarkers Revenue, Prospects & Forecasts: 2018-2035
2.3 Global Lung Cancer Biomarkers Sales: 2018-2035
3 Company Landscape
3.1 Top Lung Cancer Biomarkers Players in Global Market
3.2 Top Global Lung Cancer Biomarkers Companies Ranked by Revenue
3.3 Global Lung Cancer Biomarkers Revenue by Companies
3.4 Global Lung Cancer Biomarkers Sales by Companies
3.5 Global Lung Cancer Biomarkers Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Lung Cancer Biomarkers Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Lung Cancer Biomarkers Product Type
3.8 Tier 1, Tier 2 and Tier 3 Lung Cancer Biomarkers Players in Global Market
3.8.1 List of Global Tier 1 Lung Cancer Biomarkers Companies
3.8.2 List of Global Tier 2 and Tier 3 Lung Cancer Biomarkers Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Lung Cancer Biomarkers Market Size Markets, 2022 & 2035
4.1.2 Protein Biomarker
4.1.3 Genetic Biomarker
4.2 By Type - Global Lung Cancer Biomarkers Revenue & Forecasts
4.2.1 By Type - Global Lung Cancer Biomarkers Revenue, 2018-2023
4.2.2 By Type - Global Lung Cancer Biomarkers Revenue, 2024-2035
4.2.3 By Type - Global Lung Cancer Biomarkers Revenue Market Share, 2018-2035
4.3 By Type - Global Lung Cancer Biomarkers Sales & Forecasts
4.3.1 By Type - Global Lung Cancer Biomarkers Sales, 2018-2023
4.3.2 By Type - Global Lung Cancer Biomarkers Sales, 2024-2035
4.3.3 By Type - Global Lung Cancer Biomarkers Sales Market Share, 2018-2035
4.4 By Type - Global Lung Cancer Biomarkers Price (Manufacturers Selling Prices), 2018-2035
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Lung Cancer Biomarkers Market Size, 2022 & 2035
5.1.2 Diagnostics
5.1.3 Research
5.1.4 Others
5.2 By Application - Global Lung Cancer Biomarkers Revenue & Forecasts
5.2.1 By Application - Global Lung Cancer Biomarkers Revenue, 2018-2023
5.2.2 By Application - Global Lung Cancer Biomarkers Revenue, 2024-2035
5.2.3 By Application - Global Lung Cancer Biomarkers Revenue Market Share, 2018-2035
5.3 By Application - Global Lung Cancer Biomarkers Sales & Forecasts
5.3.1 By Application - Global Lung Cancer Biomarkers Sales, 2018-2023
5.3.2 By Application - Global Lung Cancer Biomarkers Sales, 2024-2035
5.3.3 By Application - Global Lung Cancer Biomarkers Sales Market Share, 2018-2035
5.4 By Application - Global Lung Cancer Biomarkers Price (Manufacturers Selling Prices), 2018-2035
6 Sights by Region
6.1 By Region - Global Lung Cancer Biomarkers Market Size, 2022 & 2035
6.2 By Region - Global Lung Cancer Biomarkers Revenue & Forecasts
6.2.1 By Region - Global Lung Cancer Biomarkers Revenue, 2018-2023
6.2.2 By Region - Global Lung Cancer Biomarkers Revenue, 2024-2035
6.2.3 By Region - Global Lung Cancer Biomarkers Revenue Market Share, 2018-2035
6.3 By Region - Global Lung Cancer Biomarkers Sales & Forecasts
6.3.1 By Region - Global Lung Cancer Biomarkers Sales, 2018-2023
6.3.2 By Region - Global Lung Cancer Biomarkers Sales, 2024-2035
6.3.3 By Region - Global Lung Cancer Biomarkers Sales Market Share, 2018-2035
6.4 North America
6.4.1 By Country - North America Lung Cancer Biomarkers Revenue, 2018-2035
6.4.2 By Country - North America Lung Cancer Biomarkers Sales, 2018-2035
6.4.3 US Lung Cancer Biomarkers Market Size, 2018-2035
6.4.4 Canada Lung Cancer Biomarkers Market Size, 2018-2035
6.4.5 Mexico Lung Cancer Biomarkers Market Size, 2018-2035
6.5 Europe
6.5.1 By Country - Europe Lung Cancer Biomarkers Revenue, 2018-2035
6.5.2 By Country - Europe Lung Cancer Biomarkers Sales, 2018-2035
6.5.3 Germany Lung Cancer Biomarkers Market Size, 2018-2035
6.5.4 France Lung Cancer Biomarkers Market Size, 2018-2035
6.5.5 U.K. Lung Cancer Biomarkers Market Size, 2018-2035
6.5.6 Italy Lung Cancer Biomarkers Market Size, 2018-2035
6.5.7 Russia Lung Cancer Biomarkers Market Size, 2018-2035
6.5.8 Nordic Countries Lung Cancer Biomarkers Market Size, 2018-2035
6.5.9 Benelux Lung Cancer Biomarkers Market Size, 2018-2035
6.6 Asia
6.6.1 By Region - Asia Lung Cancer Biomarkers Revenue, 2018-2035
6.6.2 By Region - Asia Lung Cancer Biomarkers Sales, 2018-2035
6.6.3 China Lung Cancer Biomarkers Market Size, 2018-2035
6.6.4 Japan Lung Cancer Biomarkers Market Size, 2018-2035
6.6.5 South Korea Lung Cancer Biomarkers Market Size, 2018-2035
6.6.6 Southeast Asia Lung Cancer Biomarkers Market Size, 2018-2035
6.6.7 India Lung Cancer Biomarkers Market Size, 2018-2035
6.7 South America
6.7.1 By Country - South America Lung Cancer Biomarkers Revenue, 2018-2035
6.7.2 By Country - South America Lung Cancer Biomarkers Sales, 2018-2035
6.7.3 Brazil Lung Cancer Biomarkers Market Size, 2018-2035
6.7.4 Argentina Lung Cancer Biomarkers Market Size, 2018-2035
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Lung Cancer Biomarkers Revenue, 2018-2035
6.8.2 By Country - Middle East & Africa Lung Cancer Biomarkers Sales, 2018-2035
6.8.3 Turkey Lung Cancer Biomarkers Market Size, 2018-2035
6.8.4 Israel Lung Cancer Biomarkers Market Size, 2018-2035
6.8.5 Saudi Arabia Lung Cancer Biomarkers Market Size, 2018-2035
6.8.6 UAE Lung Cancer Biomarkers Market Size, 2018-2035
7 Manufacturers & Brands Profiles
7.1 Bio-Rad Laboratories
7.1.1 Bio-Rad Laboratories Company Summary
7.1.2 Bio-Rad Laboratories Business Overview
7.1.3 Bio-Rad Laboratories Lung Cancer Biomarkers Major Product Offerings
7.1.4 Bio-Rad Laboratories Lung Cancer Biomarkers Sales and Revenue in Global (2018-2023)
7.1.5 Bio-Rad Laboratories Key News & Latest Developments
7.2 Roche Diagnostics
7.2.1 Roche Diagnostics Company Summary
7.2.2 Roche Diagnostics Business Overview
7.2.3 Roche Diagnostics Lung Cancer Biomarkers Major Product Offerings
7.2.4 Roche Diagnostics Lung Cancer Biomarkers Sales and Revenue in Global (2018-2023)
7.2.5 Roche Diagnostics Key News & Latest Developments
7.3 Qiagen
7.3.1 Qiagen Company Summary
7.3.2 Qiagen Business Overview
7.3.3 Qiagen Lung Cancer Biomarkers Major Product Offerings
7.3.4 Qiagen Lung Cancer Biomarkers Sales and Revenue in Global (2018-2023)
7.3.5 Qiagen Key News & Latest Developments
7.4 Illumina
7.4.1 Illumina Company Summary
7.4.2 Illumina Business Overview
7.4.3 Illumina Lung Cancer Biomarkers Major Product Offerings
7.4.4 Illumina Lung Cancer Biomarkers Sales and Revenue in Global (2018-2023)
7.4.5 Illumina Key News & Latest Developments
7.5 GE Healthcare
7.5.1 GE Healthcare Company Summary
7.5.2 GE Healthcare Business Overview
7.5.3 GE Healthcare Lung Cancer Biomarkers Major Product Offerings
7.5.4 GE Healthcare Lung Cancer Biomarkers Sales and Revenue in Global (2018-2023)
7.5.5 GE Healthcare Key News & Latest Developments
7.6 Agilent Technologies
7.6.1 Agilent Technologies Company Summary
7.6.2 Agilent Technologies Business Overview
7.6.3 Agilent Technologies Lung Cancer Biomarkers Major Product Offerings
7.6.4 Agilent Technologies Lung Cancer Biomarkers Sales and Revenue in Global (2018-2023)
7.6.5 Agilent Technologies Key News & Latest Developments
7.7 Biomerieux SA
7.7.1 Biomerieux SA Company Summary
7.7.2 Biomerieux SA Business Overview
7.7.3 Biomerieux SA Lung Cancer Biomarkers Major Product Offerings
7.7.4 Biomerieux SA Lung Cancer Biomarkers Sales and Revenue in Global (2018-2023)
7.7.5 Biomerieux SA Key News & Latest Developments
7.8 Merck
7.8.1 Merck Company Summary
7.8.2 Merck Business Overview
7.8.3 Merck Lung Cancer Biomarkers Major Product Offerings
7.8.4 Merck Lung Cancer Biomarkers Sales and Revenue in Global (2018-2023)
7.8.5 Merck Key News & Latest Developments
7.9 Abbott Laboratories
7.9.1 Abbott Laboratories Company Summary
7.9.2 Abbott Laboratories Business Overview
7.9.3 Abbott Laboratories Lung Cancer Biomarkers Major Product Offerings
7.9.4 Abbott Laboratories Lung Cancer Biomarkers Sales and Revenue in Global (2018-2023)
7.9.5 Abbott Laboratories Key News & Latest Developments
7.10 Becton, Dickinson and Company
7.10.1 Becton, Dickinson and Company Company Summary
7.10.2 Becton, Dickinson and Company Business Overview
7.10.3 Becton, Dickinson and Company Lung Cancer Biomarkers Major Product Offerings
7.10.4 Becton, Dickinson and Company Lung Cancer Biomarkers Sales and Revenue in Global (2018-2023)
7.10.5 Becton, Dickinson and Company Key News & Latest Developments
7.11 Danaher Corporation
7.11.1 Danaher Corporation Company Summary
7.11.2 Danaher Corporation Lung Cancer Biomarkers Business Overview
7.11.3 Danaher Corporation Lung Cancer Biomarkers Major Product Offerings
7.11.4 Danaher Corporation Lung Cancer Biomarkers Sales and Revenue in Global (2018-2023)
7.11.5 Danaher Corporation Key News & Latest Developments
7.12 Myriad Genetics
7.12.1 Myriad Genetics Company Summary
7.12.2 Myriad Genetics Lung Cancer Biomarkers Business Overview
7.12.3 Myriad Genetics Lung Cancer Biomarkers Major Product Offerings
7.12.4 Myriad Genetics Lung Cancer Biomarkers Sales and Revenue in Global (2018-2023)
7.12.5 Myriad Genetics Key News & Latest Developments
7.13 Sysmex Corporation
7.13.1 Sysmex Corporation Company Summary
7.13.2 Sysmex Corporation Lung Cancer Biomarkers Business Overview
7.13.3 Sysmex Corporation Lung Cancer Biomarkers Major Product Offerings
7.13.4 Sysmex Corporation Lung Cancer Biomarkers Sales and Revenue in Global (2018-2023)
7.13.5 Sysmex Corporation Key News & Latest Developments
7.14 Hologic
7.14.1 Hologic Company Summary
7.14.2 Hologic Business Overview
7.14.3 Hologic Lung Cancer Biomarkers Major Product Offerings
7.14.4 Hologic Lung Cancer Biomarkers Sales and Revenue in Global (2018-2023)
7.14.5 Hologic Key News & Latest Developments
8 Global Lung Cancer Biomarkers Production Capacity, Analysis
8.1 Global Lung Cancer Biomarkers Production Capacity, 2018-2035
8.2 Lung Cancer Biomarkers Production Capacity of Key Manufacturers in Global Market
8.3 Global Lung Cancer Biomarkers Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Lung Cancer Biomarkers Supply Chain Analysis
10.1 Lung Cancer Biomarkers Industry Value Chain
10.2 Lung Cancer Biomarkers Upstream Market
10.3 Lung Cancer Biomarkers Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Lung Cancer Biomarkers Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Lung Cancer Biomarkers in Global Market
Table 2. Top Lung Cancer Biomarkers Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Lung Cancer Biomarkers Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Lung Cancer Biomarkers Revenue Share by Companies, 2018-2023
Table 5. Global Lung Cancer Biomarkers Sales by Companies, (Units), 2018-2023
Table 6. Global Lung Cancer Biomarkers Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Lung Cancer Biomarkers Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Lung Cancer Biomarkers Product Type
Table 9. List of Global Tier 1 Lung Cancer Biomarkers Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Lung Cancer Biomarkers Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Lung Cancer Biomarkers Revenue, (US$, Mn), 2022 & 2035
Table 12. By Type - Global Lung Cancer Biomarkers Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Lung Cancer Biomarkers Revenue (US$, Mn), 2024-2035
Table 14. By Type - Global Lung Cancer Biomarkers Sales (Units), 2018-2023
Table 15. By Type - Global Lung Cancer Biomarkers Sales (Units), 2024-2035
Table 16. By Application ? Global Lung Cancer Biomarkers Revenue, (US$, Mn), 2022 & 2035
Table 17. By Application - Global Lung Cancer Biomarkers Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Lung Cancer Biomarkers Revenue (US$, Mn), 2024-2035
Table 19. By Application - Global Lung Cancer Biomarkers Sales (Units), 2018-2023
Table 20. By Application - Global Lung Cancer Biomarkers Sales (Units), 2024-2035
Table 21. By Region ? Global Lung Cancer Biomarkers Revenue, (US$, Mn), 2022 VS 2035
Table 22. By Region - Global Lung Cancer Biomarkers Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Lung Cancer Biomarkers Revenue (US$, Mn), 2024-2035
Table 24. By Region - Global Lung Cancer Biomarkers Sales (Units), 2018-2023
Table 25. By Region - Global Lung Cancer Biomarkers Sales (Units), 2024-2035
Table 26. By Country - North America Lung Cancer Biomarkers Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Lung Cancer Biomarkers Revenue, (US$, Mn), 2024-2035
Table 28. By Country - North America Lung Cancer Biomarkers Sales, (Units), 2018-2023
Table 29. By Country - North America Lung Cancer Biomarkers Sales, (Units), 2024-2035
Table 30. By Country - Europe Lung Cancer Biomarkers Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Lung Cancer Biomarkers Revenue, (US$, Mn), 2024-2035
Table 32. By Country - Europe Lung Cancer Biomarkers Sales, (Units), 2018-2023
Table 33. By Country - Europe Lung Cancer Biomarkers Sales, (Units), 2024-2035
Table 34. By Region - Asia Lung Cancer Biomarkers Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Lung Cancer Biomarkers Revenue, (US$, Mn), 2024-2035
Table 36. By Region - Asia Lung Cancer Biomarkers Sales, (Units), 2018-2023
Table 37. By Region - Asia Lung Cancer Biomarkers Sales, (Units), 2024-2035
Table 38. By Country - South America Lung Cancer Biomarkers Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Lung Cancer Biomarkers Revenue, (US$, Mn), 2024-2035
Table 40. By Country - South America Lung Cancer Biomarkers Sales, (Units), 2018-2023
Table 41. By Country - South America Lung Cancer Biomarkers Sales, (Units), 2024-2035
Table 42. By Country - Middle East & Africa Lung Cancer Biomarkers Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Lung Cancer Biomarkers Revenue, (US$, Mn), 2024-2035
Table 44. By Country - Middle East & Africa Lung Cancer Biomarkers Sales, (Units), 2018-2023
Table 45. By Country - Middle East & Africa Lung Cancer Biomarkers Sales, (Units), 2024-2035
Table 46. Bio-Rad Laboratories Company Summary
Table 47. Bio-Rad Laboratories Lung Cancer Biomarkers Product Offerings
Table 48. Bio-Rad Laboratories Lung Cancer Biomarkers Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Bio-Rad Laboratories Key News & Latest Developments
Table 50. Roche Diagnostics Company Summary
Table 51. Roche Diagnostics Lung Cancer Biomarkers Product Offerings
Table 52. Roche Diagnostics Lung Cancer Biomarkers Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Roche Diagnostics Key News & Latest Developments
Table 54. Qiagen Company Summary
Table 55. Qiagen Lung Cancer Biomarkers Product Offerings
Table 56. Qiagen Lung Cancer Biomarkers Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Qiagen Key News & Latest Developments
Table 58. Illumina Company Summary
Table 59. Illumina Lung Cancer Biomarkers Product Offerings
Table 60. Illumina Lung Cancer Biomarkers Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Illumina Key News & Latest Developments
Table 62. GE Healthcare Company Summary
Table 63. GE Healthcare Lung Cancer Biomarkers Product Offerings
Table 64. GE Healthcare Lung Cancer Biomarkers Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. GE Healthcare Key News & Latest Developments
Table 66. Agilent Technologies Company Summary
Table 67. Agilent Technologies Lung Cancer Biomarkers Product Offerings
Table 68. Agilent Technologies Lung Cancer Biomarkers Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Agilent Technologies Key News & Latest Developments
Table 70. Biomerieux SA Company Summary
Table 71. Biomerieux SA Lung Cancer Biomarkers Product Offerings
Table 72. Biomerieux SA Lung Cancer Biomarkers Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Biomerieux SA Key News & Latest Developments
Table 74. Merck Company Summary
Table 75. Merck Lung Cancer Biomarkers Product Offerings
Table 76. Merck Lung Cancer Biomarkers Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Merck Key News & Latest Developments
Table 78. Abbott Laboratories Company Summary
Table 79. Abbott Laboratories Lung Cancer Biomarkers Product Offerings
Table 80. Abbott Laboratories Lung Cancer Biomarkers Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Abbott Laboratories Key News & Latest Developments
Table 82. Becton, Dickinson and Company Company Summary
Table 83. Becton, Dickinson and Company Lung Cancer Biomarkers Product Offerings
Table 84. Becton, Dickinson and Company Lung Cancer Biomarkers Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Becton, Dickinson and Company Key News & Latest Developments
Table 86. Danaher Corporation Company Summary
Table 87. Danaher Corporation Lung Cancer Biomarkers Product Offerings
Table 88. Danaher Corporation Lung Cancer Biomarkers Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Danaher Corporation Key News & Latest Developments
Table 90. Myriad Genetics Company Summary
Table 91. Myriad Genetics Lung Cancer Biomarkers Product Offerings
Table 92. Myriad Genetics Lung Cancer Biomarkers Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. Myriad Genetics Key News & Latest Developments
Table 94. Sysmex Corporation Company Summary
Table 95. Sysmex Corporation Lung Cancer Biomarkers Product Offerings
Table 96. Sysmex Corporation Lung Cancer Biomarkers Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. Sysmex Corporation Key News & Latest Developments
Table 98. Hologic Company Summary
Table 99. Hologic Lung Cancer Biomarkers Product Offerings
Table 100. Hologic Lung Cancer Biomarkers Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 101. Hologic Key News & Latest Developments
Table 102. Lung Cancer Biomarkers Production Capacity (Units) of Key Manufacturers in Global Market, 2021-2023 (Units)
Table 103. Global Lung Cancer Biomarkers Capacity Market Share of Key Manufacturers, 2021-2023
Table 104. Global Lung Cancer Biomarkers Production by Region, 2018-2023 (Units)
Table 105. Global Lung Cancer Biomarkers Production by Region, 2024-2035 (Units)
Table 106. Lung Cancer Biomarkers Market Opportunities & Trends in Global Market
Table 107. Lung Cancer Biomarkers Market Drivers in Global Market
Table 108. Lung Cancer Biomarkers Market Restraints in Global Market
Table 109. Lung Cancer Biomarkers Raw Materials
Table 110. Lung Cancer Biomarkers Raw Materials Suppliers in Global Market
Table 111. Typical Lung Cancer Biomarkers Downstream
Table 112. Lung Cancer Biomarkers Downstream Clients in Global Market
Table 113. Lung Cancer Biomarkers Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Lung Cancer Biomarkers Segment by Type in 2022
Figure 2. Lung Cancer Biomarkers Segment by Application in 2022
Figure 3. Global Lung Cancer Biomarkers Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Lung Cancer Biomarkers Market Size: 2022 VS 2035 (US$, Mn)
Figure 6. Global Lung Cancer Biomarkers Revenue, 2018-2035 (US$, Mn)
Figure 7. Lung Cancer Biomarkers Sales in Global Market: 2018-2035 (Units)
Figure 8. The Top 3 and 5 Players Market Share by Lung Cancer Biomarkers Revenue in 2022
Figure 9. By Type - Global Lung Cancer Biomarkers Revenue, (US$, Mn), 2022 & 2035
Figure 10. By Type - Global Lung Cancer Biomarkers Revenue Market Share, 2018-2035
Figure 11. By Type - Global Lung Cancer Biomarkers Sales Market Share, 2018-2035
Figure 12. By Type - Global Lung Cancer Biomarkers Price (US$/Unit), 2018-2035
Figure 13. By Application - Global Lung Cancer Biomarkers Revenue, (US$, Mn), 2022 & 2035
Figure 14. By Application - Global Lung Cancer Biomarkers Revenue Market Share, 2018-2035
Figure 15. By Application - Global Lung Cancer Biomarkers Sales Market Share, 2018-2035
Figure 16. By Application - Global Lung Cancer Biomarkers Price (US$/Unit), 2018-2035
Figure 17. By Region - Global Lung Cancer Biomarkers Revenue, (US$, Mn), 2022 & 2035
Figure 18. By Region - Global Lung Cancer Biomarkers Revenue Market Share, 2018 VS 2022 VS 2035
Figure 19. By Region - Global Lung Cancer Biomarkers Revenue Market Share, 2018-2035
Figure 20. By Region - Global Lung Cancer Biomarkers Sales Market Share, 2018-2035
Figure 21. By Country - North America Lung Cancer Biomarkers Revenue Market Share, 2018-2035
Figure 22. By Country - North America Lung Cancer Biomarkers Sales Market Share, 2018-2035
Figure 23. US Lung Cancer Biomarkers Revenue, (US$, Mn), 2018-2035
Figure 24. Canada Lung Cancer Biomarkers Revenue, (US$, Mn), 2018-2035
Figure 25. Mexico Lung Cancer Biomarkers Revenue, (US$, Mn), 2018-2035
Figure 26. By Country - Europe Lung Cancer Biomarkers Revenue Market Share, 2018-2035
Figure 27. By Country - Europe Lung Cancer Biomarkers Sales Market Share, 2018-2035
Figure 28. Germany Lung Cancer Biomarkers Revenue, (US$, Mn), 2018-2035
Figure 29. France Lung Cancer Biomarkers Revenue, (US$, Mn), 2018-2035
Figure 30. U.K. Lung Cancer Biomarkers Revenue, (US$, Mn), 2018-2035
Figure 31. Italy Lung Cancer Biomarkers Revenue, (US$, Mn), 2018-2035
Figure 32. Russia Lung Cancer Biomarkers Revenue, (US$, Mn), 2018-2035
Figure 33. Nordic Countries Lung Cancer Biomarkers Revenue, (US$, Mn), 2018-2035
Figure 34. Benelux Lung Cancer Biomarkers Revenue, (US$, Mn), 2018-2035
Figure 35. By Region - Asia Lung Cancer Biomarkers Revenue Market Share, 2018-2035
Figure 36. By Region - Asia Lung Cancer Biomarkers Sales Market Share, 2018-2035
Figure 37. China Lung Cancer Biomarkers Revenue, (US$, Mn), 2018-2035
Figure 38. Japan Lung Cancer Biomarkers Revenue, (US$, Mn), 2018-2035
Figure 39. South Korea Lung Cancer Biomarkers Revenue, (US$, Mn), 2018-2035
Figure 40. Southeast Asia Lung Cancer Biomarkers Revenue, (US$, Mn), 2018-2035
Figure 41. India Lung Cancer Biomarkers Revenue, (US$, Mn), 2018-2035
Figure 42. By Country - South America Lung Cancer Biomarkers Revenue Market Share, 2018-2035
Figure 43. By Country - South America Lung Cancer Biomarkers Sales Market Share, 2018-2035
Figure 44. Brazil Lung Cancer Biomarkers Revenue, (US$, Mn), 2018-2035
Figure 45. Argentina Lung Cancer Biomarkers Revenue, (US$, Mn), 2018-2035
Figure 46. By Country - Middle East & Africa Lung Cancer Biomarkers Revenue Market Share, 2018-2035
Figure 47. By Country - Middle East & Africa Lung Cancer Biomarkers Sales Market Share, 2018-2035
Figure 48. Turkey Lung Cancer Biomarkers Revenue, (US$, Mn), 2018-2035
Figure 49. Israel Lung Cancer Biomarkers Revenue, (US$, Mn), 2018-2035
Figure 50. Saudi Arabia Lung Cancer Biomarkers Revenue, (US$, Mn), 2018-2035
Figure 51. UAE Lung Cancer Biomarkers Revenue, (US$, Mn), 2018-2035
Figure 52. Global Lung Cancer Biomarkers Production Capacity (Units), 2018-2035
Figure 53. The Percentage of Production Lung Cancer Biomarkers by Region, 2022 VS 2035
Figure 54. Lung Cancer Biomarkers Industry Value Chain
Figure 55. Marketing Channels
